MarketPulse

vaccine sales decline

2 articles
BenzingaBenzinga··Vandana Singh

BioNTech Shares Tumble as COVID Vaccine Demand Wanes, Major Restructuring Looms

BioNTech shares fell 3% on Q1 revenue miss as COVID vaccine sales decline. Company announced €500M cost-cutting restructuring targeting 2029 completion.
BNTXrestructuringcost savings
BenzingaBenzinga··Vandana Singh

Sanofi Shares Slide as Hudson Steps Down; Garijo to Lead Post-AGM

Sanofi CEO Paul Hudson steps down February 17; Belén Garijo takes over post-AGM. Stock fell 4.5% on leadership transition announcement amid vaccine sales decline concerns.
SNYREGNstock declineCEO transition